Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin vs trazodone vs clonazepam for sleep disorders in Parkinson's disease
IRCT20170821035819N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin, trazodone and clonazepam in sleep disorder and Parkinson's disease (PD) (3 arms), sponsored by Tehran University of Medical Sciences. Started Jul 2019; status: completed.
02
Drugs
melatonintrazodoneclonazepam
03
Conditions
sleep disorderParkinson's disease (PD)
Beyond the preview
Go deeper on IRCT20170821035819N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170821035819N2.